These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 580585)

  • 1. [Metabolism of meproscillarin in man (author's transl)].
    Rietbrock N
    Arzneimittelforschung; 1978; 28(3a):540-5. PubMed ID: 580585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on the disposition of meproscillarin in rat and dog (author's transl)].
    Weymann J; Schenk G; Kesselring K
    Arzneimittelforschung; 1978; 28(3a):520-6. PubMed ID: 580582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Elimination rate of meproscillarin following repeated application in patients with reduced renal function (author's transl)].
    Beckmann H; Belz GG; Quellhorst E
    Arzneimittelforschung; 1978; 28(3a):565-7. PubMed ID: 580592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On the possible meproscillarin accumulation in patients with impaired renal function (author's transl)].
    Twittenhoff WD; Brittinger WD; Deckert DW; Belz GG; Schubert I
    Arzneimittelforschung; 1978; 28(3a):562-5. PubMed ID: 580591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Elimination of meproscillarin by hemoperfusion (author's transl)].
    Rupp M; Brass H; Belz GG
    Arzneimittelforschung; 1978; 28(3a):567-9. PubMed ID: 580593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term study with the novel cardiac glycoside meproscillarin (author's transl)].
    Eckardt A; Koch W; Safer A
    Arzneimittelforschung; 1978; 28(3a):570-3. PubMed ID: 348206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preliminary hemodynamic studies on the activity of meproscillarin (author's transl)].
    Klein WW; Pavek P
    Arzneimittelforschung; 1978; 28(3a):553-5. PubMed ID: 580588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The influence of meproscillarin on human left ventricular function (author's transl)].
    Turina J; Krayenbühl HP
    Arzneimittelforschung; 1978; 28(3a):555-7. PubMed ID: 580589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study of meproscillarin rates of inactivation and persistence, bioavailability and maintenance dose].
    Herken H; Brandes J
    Arzneimittelforschung; 1978; 28(3a):557-60. PubMed ID: 580590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Labelling meproscillarin with tritium at the C-19 position (author's transl)].
    Schenk G; Albrecht HP; Lietz H
    Arzneimittelforschung; 1978; 28(3a):518-9. PubMed ID: 580581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of meproscillarin on left ventricular hemodynamics (author's transl)].
    Pachinger O; Probst P
    Arzneimittelforschung; 1978; 28(3a):550-2. PubMed ID: 580587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On the development of an oral preparation of meproscillarin (author's transl)].
    Einig H; Mayer D
    Arzneimittelforschung; 1978; 28(3a):527-31. PubMed ID: 580583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical observations during accumulative oral glycoside therapy with meproscillarin (author's transl)].
    Pozenel H
    Arzneimittelforschung; 1978; 28(3a):560-2. PubMed ID: 348205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Meproscillarin, a new semisynthetic cardiac glycoside/chemistry and physical properties (author's transl)].
    Kubinyi H
    Arzneimittelforschung; 1978; 28(3a):493-5. PubMed ID: 580577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of the calcium antagonist gallopamil in man.
    Weymann J; Bühler V; Hege HG; Müller-Peltzer H; Schenk G; Stieren B; Hollmann M
    Arzneimittelforschung; 1989 May; 39(5):605-7. PubMed ID: 2757679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
    Prakash C; Soliman V
    Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile.
    Balani SK; Xu X; Pratha V; Koss MA; Amin RD; Dufresne C; Miller RR; Arison BH; Doss GA; Chiba M; Freeman A; Holland SD; Schwartz JI; Lasseter KC; Gertz BJ; Isenberg JI; Rogers JD; Lin JH; Baillie TA
    Drug Metab Dispos; 1997 Nov; 25(11):1282-7. PubMed ID: 9351905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic disposition of (S)-2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine in rats, dogs, and humans.
    Vickers S; Duncan CA; Arison BH; Davies RO; Ferguson R; Zacchei AG
    Drug Metab Dispos; 1980; 8(3):163-7. PubMed ID: 6104580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.